Establishment and characterization of a novel MYC/BCL2 “double-hit” diffuse large B cell lymphoma cell line, RC

gan Pham, Lan V., Lu, Gary, Tamayo, Archito T., Chen, Juan, Challagundla, Pramoda, Jorgensen, Jeffrey L., Medeiros, L. Jeffrey, Ford, Richard J.
Cyhoeddwyd yn J Hematol Oncol (2015)

Utility of Quantitative Flow Cytometry Immunophenotypic Analysis of CD5 Expression in Small B-cell Neoplasms

gan Challagundla, Pramoda, Jorgensen, Jeffrey L., Kanagal-Shamanna, Rashmi, Gurevich, Inga, Pierson, Diane M., Ferrajoli, Alessandra, Reyes, Steven R., Medeiros, L. Jeffrey, Miranda, Roberto N.
Cyhoeddwyd 2014

Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed dise...

gan Pham, Lan V., Vang, Muychi T., Tamayo, Archito T., Lu, Gary, Challagundla, Pramoda, Jorgensen, Jeffrey L., Rollo, Alex A., Ou, Zhishuo, Zhang, Liang, Wang, Michael, Ford, Richard J.
Cyhoeddwyd yn Leuk Lymphoma (2014)

Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL

gan Strati, Paolo, Keating, Michael J., O'Brien, Susan M., Burger, Jan, Ferrajoli, Alessandra, Jain, Nitin, Tambaro, Francesco Paolo, Estrov, Zeev, Jorgensen, Jeffrey, Challagundla, Pramoda, Faderl, Stefan H., Wierda, William G.
Cyhoeddwyd 2014

Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia

gan Ravandi, Farhad, O'Brien, Susan, Jorgensen, Jeffrey, Pierce, Sherry, Faderl, Stefan, Ferrajoli, Alessandra, Koller, Charles, Challagundla, Pramoda, York, Sergernne, Brandt, Mark, Luthra, Rajyalakshmi, Burger, Jan, Thomas, Deborah, Keating, Michael, Kantarjian, Hagop
Cyhoeddwyd 2011

Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma

gan Duvic, Madeleine, Pinter-Brown, Lauren C., Foss, Francine M., Sokol, Lubomir, Jorgensen, Jeffrey L., Challagundla, Pramoda, Dwyer, Karen M., Zhang, Xiaoping, Kurman, Michael R., Ballerini, Rocco, Liu, Li, Kim, Youn H.
Cyhoeddwyd yn Blood (2015)

Detection of MRD may predict the outcome of patients with Philadelphia chromosome–positive ALL treated with tyrosine kinase inhibitors plus chemotherapy

gan Ravandi, Farhad, Jorgensen, Jeffrey L., Thomas, Deborah A., O’Brien, Susan, Garris, Rebecca, Faderl, Stefan, Huang, Xuelin, Wen, Sijin, Burger, Jan A., Ferrajoli, Alessandra, Kebriaei, Partow, Champlin, Richard E., Estrov, Zeev, Challagundla, Pramoda, Wang, Sa A., Luthra, Rajyalakshmi, Cortes, Jorge E., Kantarjian, Hagop M.
Cyhoeddwyd 2013